Patient Recruitment/Retention Featured Articles

51. Key Takeaways From Clinical Trial Diversity Discussion 9/24/2024

    During the Clinical Leader Live, The Diversity Mandate: Effective Strategies in Clinical Trials”, we discussed everything from the guidance, to diversity action plans, to the need for better data on race, ethnicity, and identity. In this article, we also share 25 questions audience members had regarding this hot topic.

52. Why Industry Must Design Alzheimer's Trials To Include People With Down Syndrome 9/24/2024

    The recruitment and enrollment of people with Down syndrome involve special challenges, but these challenges can be addressed with proper planning and education.

53. Patients Get More Mileage With Free Flights To Far-Flung Clinical Trial Sites 9/20/2024

    LifeLine Pilot Executive Director Lindsey Kerr shares the impact free medical flights can have on patients participating in clinical trials far from home.

54. We Need More Clinical Trial Awareness … Oh, And CRCs 9/19/2024

    Christina Brennan, SVP for the clinical research program at Northwell Health, talks about how increasing the awareness of clinical trials can lead to better patient-centricity and why we need to start positioning clinical research as a career. 

55. Why Is The Reality Of Patient Engagement Not Living Up To Its Theory? 9/17/2024

    Patient Co-Next's Pauline Frank discusses why pharma knows patient engagement is important but rarely succeeds in implementing it fully.

56. If Sponsors Invite Patients To See The Final Draft Protocol, It's Already Too Late 9/17/2024

    Consultant Kamila Novak dives into the importance of early patient input — and why sponsors have a hard time getting it (and implementing it).

57. Why Are We Still Excluding Persons With Disabilities (PWDs) In Clinical Trials? 9/13/2024

    Canary Advisors Cofounder and COO Richie Kahn details the National Council on Disability's call for the inclusion of people with disabilities in clinical trials.

58. 4 Steps To Help Sponsors Return Individual Patient Data 9/10/2024

    In part two of this series on individual patient data return (iPDR), Legacy Health Strategies experts offer four steps to help sponsors make iPDR a reality.

59. Returning Individual Trial Data To Patients: How And Why It Needs To Happen 9/9/2024

    Returning individual data to clinical trial participants is seen by many as "the right thing to do." Yet, its uptake is lacking. Legacy Health Strategies experts discuss why it's so important and how it can be achieved in part one of this two-part series.

60. Which Top HEOR Trends Will Have The Biggest Impact On Clinical Research? 9/6/2024

    ISPOR CEO Rob Abbott discusses Health Economics and Outcomes Research (HEOR) trends and how they're impacting clinical trials.